Table 1. Clinical data of study group (n=30).
| n | % | Mean±SD | |
| Subgroup | |||
| Limited | 18 | ||
| Diffuse disease | 12 | ||
| ANA positive | 24 | 80 | |
| Anti centromere positive | 8 | 27 | |
| Anti Scl-70 positive | 10 | 33 | |
| Diagnostic NVC (n=21) | 19 | 90 | |
| Organ involvement | |||
| Gastrointestinal | 23 | 76 | |
| Lung | 21 | 70 | |
| Heart | 19 | 63 | |
| Kidney | 0 | 0 | |
| mRodnan | 13.8±6.2 | ||
| SD: Standard deviation; ANA: Antinuclear antibody; Anti Scl-70: Anti- topoisomerase I after type I topoisomerase target; NVC: Nailfold video capillaroscopy. | |||